|
DCLRE1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.86919999981095E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.90699999627719E-08 |
| Normal-vs-Stage2 |
4.684000E-02 |
| Normal-vs-Stage3 |
2.31899999999508E-05 |
| Normal-vs-Stage4 |
2.38889999999436E-05 |
| Stage1-vs-Stage2 |
5.221900E-02 |
| Stage1-vs-Stage3 |
6.984800E-01 |
| Stage1-vs-Stage4 |
7.095000E-01 |
| Stage2-vs-Stage3 |
1.777810E-01 |
| Stage2-vs-Stage4 |
8.907900E-02 |
| Stage3-vs-Stage4 |
5.525600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50290000444642E-08 |
| Normal-vs-AfricanAmerican |
4.386300E-02 |
| Normal-vs-Asian |
1.233400E-01 |
| Caucasian-vs-AfricanAmerican |
9.397600E-02 |
| Caucasian-vs-Asian |
3.681600E-01 |
| AfricanAmerican-vs-Asian |
2.063800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.43899999880549E-08 |
| Normal-vs-Female |
5.67670000006792E-07 |
| Male-vs-Female |
9.820200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.623200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.29080000021986E-07 |
| Normal-vs-Age(61-80Yrs) |
2.74409999945213E-07 |
| Normal-vs-Age(81-100Yrs) |
2.627200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.663000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.362000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.072000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.442000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.356100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.044770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.838200E-03 |
| Normal-vs-Grade 2 |
6.98269999599432E-08 |
| Normal-vs-Grade 3 |
2.77439999996076E-06 |
| Normal-vs-Grade 4 |
3.83980000000506E-05 |
| Grade 1-vs-Grade 2 |
9.436400E-01 |
| Grade 1-vs-Grade 3 |
6.323800E-01 |
| Grade 1-vs-Grade 4 |
5.950200E-01 |
| Grade 2-vs-Grade 3 |
4.606000E-01 |
| Grade 2-vs-Grade 4 |
3.964600E-01 |
| Grade 3-vs-Grade 4 |
2.118800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.79919999904388E-08 |
| Normal-vs-ccB subtype |
1.0994000000375E-06 |
| ccA subtype-vs-ccB subtype |
8.750400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.75709999947505E-07 |
| Normal-vs-N1 |
1.712320E-02 |
| N0-vs-N1 |
2.025200E-01 |
|
|
